Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
Authors:
- Eun-Kee ParkEPEun-Kee Park
- Anthony R. JohnsonAJAnthony R. Johnson
- Deborah H. YatesDYDeborah H. Yates
- Paul S. ThomasPTPaul S. Thomas
- 1 January 2011
- journal article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 49 (1)
Abstract
Mesothelioma and ovarian cancer have been reported to have a similar pathogenesis, and for this reason it was hypothesized that there may be biomarkers in common and possibly associated with benign pleural diseases caused by asbestos exposure.Keywords
This publication has 13 references indexed in Scilit:
- Soluble Mesothelin-related Protein in an Asbestos-exposed Population: The Dust Diseases Board Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Diagnostic Markers for Early Detection of Ovarian CancerClinical Cancer Research, 2008
- Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal MesotheliomaClinical Cancer Research, 2006
- Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin LevelsNew England Journal of Medicine, 2005
- Malignant mesotheliomaThe Lancet, 2005
- Serum protein markers for early detection of ovarian cancerProceedings of the National Academy of Sciences, 2005
- Mesothelin-family proteins and diagnosis of mesotheliomaThe Lancet, 2003
- Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignanciesInternational Journal of Gynecological Cancer, 2002
- Asbestos-Related Benign Pleural DiseaseClinical Radiology, 2000
- Presence of asbestos in peritoneal malignant mesotheliomas in womenInternational Journal of Gynecological Cancer, 1999